CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields K Vanommeslaeghe, E Hatcher, C Acharya, S Kundu, S Zhong, J Shim, ... Journal of computational chemistry 31 (4), 671-690, 2010 | 7151 | 2010 |
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach C Acharya, A Coop, J E Polli, A D MacKerell Current computer-aided drug design 7 (1), 10-22, 2011 | 353 | 2011 |
An electrostatic mechanism for Ca2+-mediated regulation of gap junction channels BC Bennett, MD Purdy, KA Baker, C Acharya, WE McIntire, RC Stevens, ... Nature communications 7, 2016 | 146 | 2016 |
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo A Petty, E Myshkin, H Qin, H Guo, H Miao, GP Tochtrop, JT Hsieh, P Page, ... Public Library of Science 7 (8), e42120, 2012 | 140 | 2012 |
A diagnostic tool for population models using non-compartmental analysis: The ncappc package for R C Acharya, AC Hooker, GY Türkyılmaz, S Jönsson, MO Karlsson Computer methods and programs in biomedicine 127, 83-93, 2016 | 66 | 2016 |
Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter R Rais, C Acharya, G Tririya, AD MacKerell Jr, JE Polli Journal of medicinal chemistry 53 (12), 4749-4760, 2010 | 36 | 2010 |
Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids PM González, C Acharya, AD MacKerell Jr, JE Polli Pharmaceutical research 26 (7), 1665-1678, 2009 | 34 | 2009 |
Pharmacokinetic interactions for drugs with a long half-life—evidence for the need of model-based analysis EM Svensson, C Acharya, B Clauson, KE Dooley, MO Karlsson The AAPS Journal 18, 171-179, 2016 | 33 | 2016 |
Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates R Rais, C Acharya, AD MacKerell Jr, JE Polli Molecular pharmaceutics 7 (6), 2240-2254, 2010 | 32 | 2010 |
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim A Brekkan, L Lopez-Lazaro, G Yngman, EL Plan, C Acharya, AC Hooker, ... The AAPS journal 20 (5), 91, 2018 | 25 | 2018 |
Computational Model for Predicting Chemical Substituent Effects on Passive Drug Permeability across Parallel Artificial Membranes† C Acharya, PR Seo, JE Polli, AD MacKerell Jr Molecular pharmaceutics 5 (5), 818-828, 2008 | 23 | 2008 |
Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid X Zheng, Y Pan, C Acharya, PW Swaan, JE Polli Bioconjugate chemistry 21 (11), 2038-2048, 2010 | 22 | 2010 |
PeptiSite: a structural database of peptide binding sites in 4D C Acharya, I Kufareva, AV Ilatovskiy, R Abagyan Biochemical and biophysical research communications 445 (4), 717-723, 2014 | 12 | 2014 |
Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT V Kolhatkar, L Diao, C Acharya, AD Mackerell Jr, JE Polli Journal of pharmaceutical sciences 101 (1), 116-126, 2012 | 9 | 2012 |
Synthesis and Characterization of a Novel Diels–Alder Adduct of Codeine CW Cunningham, K Hom, C Acharya, A Wilks, AD MacKerell, A Coop Helvetica chimica acta 93 (2), 220-226, 2010 | 7 | 2010 |
A diagnostic tool for population models using non-compartmental analysis: nca_ppc functionality for R C Acharya, AC Hooker, S Jönsson, MO Karlsson Annual Meeting of the Population Approach Group in Europe, 2014 | 6 | 2014 |
Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus C Acharya, MO Magnusson, P Vajjah, R Oliver, M Zamacona The Journal of Clinical Pharmacology 63 (4), 435-444, 2023 | 1 | 2023 |
Shiny_ncappc, A Shiny App For Non-compartmental Analysis (nca). J Hibma, L Fostvedt, C Acharya, A Ruiz-Garcia Clinical Pharmacology & Therapeutics 99, S69, 2016 | | 2016 |